Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 4, Number 2, march 2004

Review article

Favourites:
ADD

Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications
pp. 147-163(17)
Authors: Kabore, Albert F.; Johnston, James B.; Gibson, Spencer B.

Favourites:
ADD

Transforming Growth Factor-β Superfamily: Evaluation as Breast Cancer Biomarkers and Preventive Agents
pp. 165-182(18)
Authors: Gupta, V.; Harkin, D. P.; Kawakubo, H.; Maheswaran, S.

Favourites:
ADD
Favourites:
ADD

Novel Fluoropyrimidines: Improving the Efficacy and Tolerability of Cytotoxic Therapy
pp. 191-204(14)
Authors: Petty, Russell D.; Cassidy, J.

Favourites:
ADD

Targeted Histone Deacetylase Inhibition for Cancer Therapy
pp. 205-218(14)
Authors: Vigushin, D. M.; Coombes, R. C.

Favourites:
ADD

AT Islands - Their Nature and Potential for Anticancer Strategies
pp. 219-234(16)
Author: Woynarowski, Jan M.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more